louisiana glp-1 bowel obstruction lawsuit gi in GLP-1 medications are now at the center of growing lawsuits across the United States. The lawsuits allege semaglutide digestive blockage legal team

As a result, some physicians may prescribe either for weight management

10.1136/tsaco-2020-000595 86 StrbeS.GojkovicS.KrezicI.ZizekH.VranesH.BarisicI.et al (2021)

This isnt an argument against GLP-1s

According to FDA labeling, the common side effects include: Gastrointestinal effects (with frequencies varying by dose): Nausea (12-30% of patients, often most prominent during dose escalation) Diarrhea (7-22%) Vomiting (2-10%) Constipation (5-17%) Abdominal pain or discomfort (5-10%) Decreased appetite (5-10%) Dyspepsia/indigestion (2-9%) Gastroesophageal reflux disease (1-5%, more common in weight management indication) Eructation/belching (more common in weight management indication) These gastrointestinal symptoms typically occur early in treatment or following dose increases and often diminish over time as the body adjusts to the medication

Richert, L., Tuschl, G., Viollon-Abadie, C., Blanchard, N., Bonet, A., Heyd, B., Halkic, N., Wimmer, E., Dolgos, H., and Mueller, S

It is not a direct menstrual treatment, but can assist recovery from pelvic tissue injury or inflammation that secondarily impacts cycles